(Q37734863)

22 August 2017

1 reference

title

The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science (English)

1 reference

22 August 2017

1

1 reference

22 August 2017

R T Myers

2

1 reference

22 August 2017

F Goodsaid

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Clinical Pharmacology & Therapeutics

22 August 2017

published in

1 reference

22 August 2017

volume

87

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

530-533

1 reference

The FDA critical path initiative and its influence on new drug development.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

Strategic paths for biomarker qualification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

Public consortium efforts in toxicogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

Translational toxicology and the work of the predictive safety testing consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical Path

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

Sematech: techno-policy in action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

inferred from DOI database lookup

7 January 2021

based on heuristic

Drug Development and the FDA's Critical Path Initiative

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.27

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.27

1 reference

22 August 2017

1 reference